Clinical trial
Implementation of Long-read Sequencing for Epimutation Detection in the Diagnosis of Rare Diseases.
NCT07400913 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Implementation of Long-read Sequencing for Epimutation Detection in the Diagnosis of Rare Diseases.
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 28, 2026
- Completion date
- February 29, 2028
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.